7.60
Anavex Life Sciences Corporation (AVXL) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
11.16%
1.075
|
1.21 | 1.394 | 1.759 | 1.796 |
|
|
15.55%
14.46
|
12.51 | 13.59 | 14.34 | 14.73 |
| Benefits Costs and Expenses |
-
|
- | - | 13.50 | 14.08 |
| Costs And Expenses |
13.20%
15.53
|
13.72 | 14.99 | 13.50 | 14.08 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Operating Income/Loss |
15.55%
-14.46
|
-12.51 | -13.59 | -14.34 | -14.73 |
| Net Interest Income/Expense |
11.16%
1.075
|
1.21 | 1.394 | 1.759 | 1.796 |
| Nonoperating Income/Loss |
7.67%
1.216
|
1.317 | 1.481 | 2.592 | 2.448 |
| Income/Loss From Continuing Operations Before Tax |
11.16%
1.075
|
1.21 | 1.394 | -11.74 | -12.28 |
| Income/Loss From Continuing Operations After Tax |
18.28%
-13.24
|
-11.20 | -12.11 | -11.62 | -12.21 |
|
|
18.28%
-13.24
|
-11.20 | -12.11 | -11.62 | -12.21 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.36%
85.38
|
85.07 | 84.81 | 0.4457 | 84.54 |
| Diluted Average Shares |
0.36%
85.38
|
85.07 | 84.81 | 0.4457 | 84.54 |
| Basic Earnings Per Share |
23.08%
-0.16
|
-0.13 | -0.14 | -0.14 | -0.14 |
| Diluted Earnings Per Share |
23.08%
-0.16
|
-0.13 | -0.14 | -0.14 | -0.14 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):